PRADO

Twitter Facebook Linkedin Youtube
logotras
Menu
Get A Quote
Get A Quote

BIOPHARMA & BIOTECHNOLOGY INDUSTRY

idustrty bio pharma

Vaccines

Biopharmaceuticals and Biotechnology are becoming increasingly important in the development of novel and less toxic therapeutics for human disease. Many of these products, including Therapeutic Proteins, Vaccines, cell-based and stem cell therapies, also need to generate preclinical information such as Efficacy and Safety assessment. The in vitro and in vivo bioassays help in the evaluation of the biological effects in human beings

The global healthcare industry has committed itself to investing in the expeditious development and use of safe vaccines to rid the planet of many new and chronic variants of zoonotic and other communicable diseases.

PRADO’s expertise is not only well-suited to meet the preclinical testing and protocol requirements of vaccine development but is also specifically designed to cater to the evolving needs of the industry. PRADO is glad to be a partner in your vaccine development journey with a range of special services offers

TOXICITY
  1. Safe Dosage Testing.
  2. Initial Safe Dosage, Subsequent Safe Dosage, Dosage Escalations.
  3. Single & Repeat Dosage Evaluations.
  4. Evaluations for Potential Reversibility of
  5.  Virulence.
  6. Reversibility Assessments of Toxoids.
  7. Inactivation Levels Assessments.
  8. Evaluations of Antigen Antibody Releases.
  9. Cross-reaction potential to human tissues.
  POTENCY  
  1. Challenge Model Assays
  2. Viral Vaccines Attenuation Evaluations
IMMUNIZATION
  1.  Immunogenicity Tests
    OTHERS
  1. Preclinical in vivo efficacy models/ Bioassays.
  2. Acute and repeat dose toxicity studies in rodents and non-rodents.
  3. Studies to predict immunotoxicity.
  4. Genetic toxicity studies.
  5. Pathological evaluations including Immunohistochemistry.